56 studies found for:    "antibiotic resistance" | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting Infant Antibiotic Resistance and Implications for Therapeutic Decision-making
Condition: Bacterial Infections and Mycoses
Intervention:
2 Not yet recruiting Clinical Microbial Species and Antibiotic Resistance Identification in Patients Presenting to the Emergency Department With Three of Four Systemic Inflammatory Response Syndrome (SIRS) Criteria - is Rapid Identification Possible and Accurate?
Conditions: Sepsis;   Systemic Inflammatory Response Syndrome
Intervention: Device: Gene Z
3 Not yet recruiting Mortality Reduction After Oral Azithromycin: Morbidity Study
Condition: Childhood Mortality
Interventions: Drug: Azithromycin;   Drug: Placebo
4 Recruiting Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals
Conditions: Infection Resistant to Drugs;   Gram-Negative Bacterial Infection
Intervention:
5 Unknown  A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye
Conditions: Central Retinal Vein Occlusion;   Choroidal Neovascularization;   Age-related Macular Degeneration;   Branch Retinal Vein Occlusion
Intervention: Procedure: Conj flora Antibiotic resistance
6 Unknown  Endophthalmitis Cultures
Condition: Endophthalmitis
Intervention:
7 Unknown  Hospital Wide Roll-Out of Antimicrobial Stewardship
Condition: Bacterial Infections
Intervention: Other: Antibiotic stewardship audit-and-feedback to prescribers of patients receiving 3rd or 10th day of targeted broadspectrum antibiotics
8 Recruiting Clinical Trials to Reduce the Risk of Antimicrobial Resistance
Condition: Bacterial Pneumonia
Interventions: Drug: IV meropenem;  parenteral aminoglycoside;   Drug: I.V. Meropenem
9 Recruiting Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication
Condition: Self Efficacy
Interventions: Drug: empirical therapy;   Drug: Genotypic resistance guided therapy
10 Unknown  Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia
Conditions: Anti-Biotic Resistance;   Klebsiella Pneumoniae
Interventions: Dietary Supplement: VSL#3;   Drug: Polyethylene glycol
11 Recruiting Impact of Probiotics for Reducing Infections in Veterans: The IMPROVE Study
Condition: Anti-biotic Resistance
Interventions: Dietary Supplement: Lactobacillus rhamnosus HN001;   Dietary Supplement: sugar pill (placebo)
12 Unknown  Antibiotic Resistant Helicobacter Pylori in Rajavithi Hospital
Condition: Dyspepsia
Intervention: Procedure: gastroscopic examination
13 Not yet recruiting Mortality Reduction After Oral Azithromycin: Mortality Study
Condition: Childhood Mortality
Interventions: Drug: Azithromycin;   Drug: Placebo
14 Not yet recruiting Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections
Conditions: Bacteremia Associated With Intravascular Line;   Ventilator Associated Pneumonia;   Bacteremia
Intervention: Drug: Neomycin Colistin Nystatin Vancomycin
15 Not yet recruiting Diagnostic Tools in Patients With a Suspected Urinary Tract Infection in Primary Care
Condition: Urinary Tract Infections
Intervention: Other: Diagnostic approaches
16 Recruiting Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: high dose dual therapy;   Drug: concomitant therapy
17 Unknown  International Travel and the Spread of Extended-spectrum Beta-lactamase-producing Escherichia Coli
Condition: Infection Due to Resistant Bacteria
Intervention: Behavioral: Analysing the behaviours of travellers while visiting India
18 Unknown  A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)
Condition: Infection
Interventions: Dietary Supplement: Lactobacillus rhamnosus;   Dietary Supplement: Sugar pill (placebo)
19 Unknown  Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections
Condition: Helicobacter Pylori Infection
Interventions: Drug: RA5-RACM7;   Drug: RA3-RACM7;   Drug: RA7-RACM7
20 Unknown  Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: 10RAC+acetylcystein;   Drug: 10RAC+metronidazole

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years